Treace Medical Concepts (TMCI) Gross Profit (2020 - 2026)

Treace Medical Concepts has reported Gross Profit for 7 years, with the latest figure at $37.4 million in Q1 2026.

• For the quarter ending Q1 2026, Gross Profit fell 10.71% year-over-year to $37.4 million; the trailing twelve-month figure through Mar 2026 stood at $165.3 million (down 2.31% YoY), and the FY2025 full-year result was $169.8 million, up 0.88% from the prior year.
• Gross Profit for Q1 2026 stood at $37.4 million, down from $50.4 million in the prior quarter.
• The five-year high for Gross Profit was $55.5 million in Q4 2024, with the low at $23.9 million in Q1 2022.
• Historically, Gross Profit has averaged $37.9 million across 5 years, with a median of $37.4 million in 2026.
• Annual changes were most pronounced in 2022 — Gross Profit soared 55.51% — and 2026, when it decreased 10.71%.
• Treace Medical Concepts' Gross Profit stood at $40.7 million in 2022, then advanced by 24.53% to $50.7 million in 2023, then grew by 9.33% to $55.5 million in 2024, then retreated by 9.15% to $50.4 million in 2025, then retreated by 25.78% to $37.4 million in 2026.
• The last three Gross Profit figures came in at $37.4 million (Q1 2026), $50.4 million (Q4 2025), and $39.7 million (Q3 2025), per Business Quant data.